08048035996
AMBISTRYN INJ Export from India to UK | Pharmaceutical Injection Supply Solutions for London

AMBISTRYN-S INJECTION

Product Description

AMBISTRYN-S Injection is a prescription antibiotic containing Streptomycin, an aminoglycoside antibacterial medicine. It is primarily used as part of combination treatment for tuberculosis (TB) and may also be used for certain other serious bacterial infections when considered appropriate by a healthcare professional. Streptomycin works by interfering with bacterial protein production, which prevents susceptible bacteria from growing and multiplying. AMBISTRYN-S is administered by a trained healthcare professional, generally by intramuscular injection. The appropriate strength and dosing schedule depend on the infection, patient factors, kidney function and the prescribed treatment protocol. Because streptomycin can affect the kidneys and hearing/balance system, medical monitoring may be required during treatment. Patients should inform their doctor about kidney disease, hearing problems, pregnancy, breastfeeding and other medicines they are taking. It should not be self-administered or used without appropriate medical supervision.

Uses of AMBISTRYN-S INJECTION

  1. Treatment of tuberculosis as part of an appropriate combination regimen.

  2. Management of selected serious bacterial infections caused by susceptible organisms.

  3. Treatment of certain cases of plague when clinically indicated.

  4. Treatment of tularemia in appropriate clinical situations.

  5. Management of other susceptible bacterial infections when prescribed by a specialist.

  6. Treatment according to established antimicrobial protocols and susceptibility considerations.

20 Frequently Asked Questions

1. What is AMBISTRYN-S Injection?
AMBISTRYN-S is a prescription antibiotic injection containing streptomycin.

2. What is the active ingredient in AMBISTRYN-S?
The active ingredient is streptomycin. The product is available in strengths including 0.75 g and 1 g.

3. What is AMBISTRYN-S Injection used for?
It is primarily used as part of combination therapy for tuberculosis and may be prescribed for selected other bacterial infections.

4. How does AMBISTRYN-S work?
Streptomycin interferes with bacterial protein production, thereby inhibiting bacterial growth and survival.

5. How is AMBISTRYN-S Injection administered?
It is generally administered by a trained healthcare professional through intramuscular injection.

6. Can AMBISTRYN-S be used for tuberculosis?
Yes. Streptomycin can be used as part of specific tuberculosis treatment regimens when clinically appropriate.

7. Is AMBISTRYN-S suitable for every TB patient?
No. The choice of TB medicines depends on the patient's infection, drug susceptibility, treatment history and applicable treatment guidelines.

8. Can AMBISTRYN-S be self-injected?
No. It should be administered by a qualified healthcare professional.

9. What are the common side effects of streptomycin?
Possible adverse effects include injection-site discomfort, dizziness, nausea, rash and effects involving hearing or balance.

10. Can AMBISTRYN-S affect hearing?
Yes. Streptomycin can cause ototoxicity, including hearing or balance problems, so monitoring may be required during treatment.

11. Can AMBISTRYN-S affect the kidneys?
Yes. Kidney function can be affected, particularly in susceptible patients, and renal monitoring may be recommended.

12. What should patients tell their doctor before receiving AMBISTRYN-S?
Tell the doctor about kidney problems, hearing or balance disorders, pregnancy, breastfeeding, allergies and all medicines being taken.

13. Can AMBISTRYN-S be used during pregnancy?
Its use during pregnancy requires careful medical assessment because streptomycin can pose risks to the developing fetus.

14. Can AMBISTRYN-S be used while breastfeeding?
Discuss breastfeeding with the treating healthcare professional before receiving this medicine.

15. Can AMBISTRYN-S interact with other medicines?
Yes. Certain medicines can increase the risk of kidney or hearing-related toxicity, so all current medicines should be disclosed to the doctor.

16. Why may hearing tests be required during treatment?
Streptomycin can affect the auditory and vestibular systems. Hearing and other monitoring may help identify toxicity early.

17. What should I do if I experience ringing in the ears or hearing changes?
Inform your healthcare professional promptly. Such symptoms can indicate possible ototoxicity.

18. Should treatment with AMBISTRYN-S be stopped when symptoms improve?
Do not stop or change the prescribed treatment without medical advice, particularly when it is being used as part of a tuberculosis regimen.

19. How should AMBISTRYN-S Injection be stored?
Storage requirements depend on the specific product and packaging. Follow the manufacturer's labeled storage instructions.

20. Is AMBISTRYN-S available from India?
Yes. Abbott India lists AMBISTRYN-S 0.75 GM and 1 GM among its pharmaceutical products, and Indian pharmaceutical listings identify India as the product's country of origin.

SEO Keywords

  • AMBISTRYN-S Injection supplier from India

  • Streptomycin injection exporter from India

  • AMBISTRYN-S pharmaceutical supplier India

  • Streptomycin antibiotic injection manufacturer India

  • AMBISTRYN-S injection export to USA

  • Streptomycin injection supplier New York USA

  • AMBISTRYN-S TB medicine exporter UK

  • Streptomycin injection supplier Birmingham UK

  • AMBISTRYN-S injection pharmaceutical exporter Canada

  • Streptomycin medicine supplier Toronto Canada

  • AMBISTRYN-S antibiotic injection Australia supplier

  • Streptomycin injection exporter Adelaide Australia

  • AMBISTRYN-S medicine supplier Singapore

  • Streptomycin injection pharmaceutical export Singapore

  • AMBISTRYN-S TB injection supplier South Korea

  • Streptomycin antibiotic exporter Seoul Korea

  • AMBISTRYN-S injection supplier Japan

  • Streptomycin injection exporter Tokyo Japan

  • Streptomycin TB medicine international supplier

  • AMBISTRYN-S injection export from India

Sep 23rd, 2026 2:29 PM

Keywords